2025/04/16 by Bianca Rocca, Emma C. Hansson, Milan Milojevic +1 · 1 voice
Medicine · #Atrial Fibrillation Management and Outcomes #Cardiac, Anesthesia and Surgical Outcomes #Heart Failure Treatment and Management
paper · pdf · doi:10.4081/btvb.2025.178
openalex publication_date 2025/04/16 · openalex created_date 2025/10/10 · openalex updated_date 2026/06/11
Guidelines are pivotal for optimal patient management and should be grounded by evidence-based medicine with accurate methodology.1 The European Association of Cardio-Thoracic Surgery has recently released the “2024 EACTS Guidelines on Perioperative Medication in Adult Cardiac Surgery”,2 which address significant novel advancements in the pharmacological management of adult patients undergoing various types of cardiac surgery, including open-heart surgery (coronary and non-coronary) and transcatheter aortic valve implantation. These guidelines comprise several drug classes and provide recommendations on their use, discontinuation and/or (re)introduction at the different phases surrounding elective, urgent or emergent cardiac interventions: early before, during, and after the operation, both short- and long-term. A substantial portion of the document focuses on antithrombotic agents, and several novel aspects and approaches warrant attention....